Nonsteroidal Anti-Inflammatory Drug-Induced Hepatic Disorders
暂无分享,去创建一个
[1] L. G. García Rodríguez,et al. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. , 1994, Archives of internal medicine.
[2] S. Gutthann,et al. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. , 1993 .
[3] B. Strom,et al. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. , 1993, Archives of internal medicine.
[4] K. Ishak,et al. Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration. , 1993, Gastroenterology.
[5] A. Walker,et al. The role of non-steroidal anti-inflammatory drugs in acute liver injury. , 1992, BMJ.
[6] H. Jick,et al. Liver Disease Associated With Diclofenac, Naproxen, and Piroxicam , 1992, Pharmacotherapy.
[7] K. Hepps,et al. Severe cholestatic jaundice associated with piroxicam. , 1991, Gastroenterology.
[8] D. Zakim,et al. Diclofenac-associated hepatotoxicity. , 1990, JAMA.
[9] H. Zimmerman,et al. Update of Hepatotoxicity Due to Classes of Drugs in Common Clinical Use: Non-Steroidal Drugs, Anti-Inflammatory Drugs, Antibiotics, Antihypertensives, and Cardiac and Psychotropic Agents , 1990, Seminars in liver disease.
[10] C. Bénichou. Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.
[11] R. Planas,et al. Fatal submassive necrosis of the liver associated with piroxicam. , 1990, The American journal of gastroenterology.
[12] S. Pignata,et al. Sulindac-induced severe hepatitis. , 1988, American Journal of Gastroenterology.
[13] M MurieCarrillodeAlbornoz,et al. [Toxic and drug-induced hepatitis]. , 1988 .
[14] R. Northington,et al. Hepatic safety of two analgesics used over the counter: Ibuprofen and aspirin , 1986, Clinical pharmacology and therapeutics.
[15] D. Samuel,et al. Emergency liver transplantation for fulminant hepatitis. , 1987, Annals of internal medicine.
[16] M. Vyberg,et al. Acute cholangitis and pancreatitis associated with sulindac (clinoril) , 1987, Histopathology.
[17] H. Jick,et al. Outpatient Drug‐Induced Parenchymal Liver Disease Requiring Hospitalization , 1986, Journal of clinical pharmacology.
[18] J. Mcnicholl,et al. Fatal hepatitis associated with diclofenac. , 1986, Gut.
[19] R. Williams,et al. Subacute hepatic necrosis induced by piroxicam. , 1986, British medical journal.
[20] C. Y. Lee,et al. Acute intoxication due to ibuprofen overdose. , 1986, Archives of Pathology & Laboratory Medicine.
[21] H. Zimmerman. Hepatic effects of oxaprozin , 1986 .
[22] D. Schapira,et al. Diclofenac-induced hepatotoxicity. , 1986, Postgraduate medical journal.
[23] L. Powell,et al. Sulindac hepatotoxicity: effects of acute and chronic exposure. , 1985, Australian and New Zealand journal of medicine.
[24] H. Jick,et al. A followup study of ibuprofen users. , 1985, The Journal of rheumatology.
[25] J. Bernuau,et al. Hépatite fulminante chez une femme prenant de la glafénine et du diclofénac. , 1985 .
[26] V. Levy,et al. [Acute fatal hepatitis during treatment with diclofenac (Voltarène)]. , 1984, Gastroenterologie clinique et biologique.
[27] C. Seckman,et al. Safety profile: fifteen years of clinical experience with ibuprofen. , 1984, The American journal of medicine.
[28] H. Hartmann,et al. Prolonged cholestatic jaundice and leukopenia associated with piroxicam. , 1984, Zeitschrift fur Gastroenterologie.
[29] Lewis Jh. Hepatic toxicity of nonsteroidal anti-inflammatory drugs. , 1984 .
[30] R. Spector,et al. Serious adverse reactions associated with sulindac. , 1982, Archives of internal medicine.
[31] Y. Giroux,et al. Cholestatic jaundice caused by sulindac. , 1982, Canadian journal of surgery. Journal canadien de chirurgie.
[32] E. Brewer,et al. The toxicity of nonsteroidal antiinflammatory drugs in juvenile rheumatoid arthritis. , 1982, The Journal of rheumatology.
[33] E. Fagman,et al. Hepatitis associated with use of sulindac in a child. , 1981, The Journal of pediatrics.
[34] K. Ishak,et al. Phenylbutazone liver injury: A clinical‐pathologic survey of 23 cases and review of the literature , 1981, Hepatology.
[35] D. Labrecque,et al. Sulindac (Clinoril) hepatitis. , 1981, Gastroenterology.
[36] F. Smith,et al. Life-threatening hypersensitivity to sulindac. , 1980, JAMA.
[37] M. Moura,et al. JAUNDICE ASSOCIATED WITH NAPROXEN , 1980, Postgraduate medical journal.
[38] Van Berge Henegouwen Gp,et al. Drug-induced liver injury. , 1980 .
[39] J. Bravo,et al. Fatty liver and pleural effusion with ibuprofen therapy. , 1977, Annals of internal medicine.
[40] J. Miller,et al. Lymphopenia and hepatic toxicity with ibuprofen. , 1977, The Journal of pediatrics.
[41] I. Law,et al. Jaundice associated with naproxen. , 1976, New England Journal of Medicine.
[42] Leon Schiff,et al. Diseases of the liver , 1975 .
[43] M. Cuthbert. Section 4 Adverse reactions to non-steroidal antirheumatic drugs , 1974 .
[44] B. H. Bass. Letter: Jaundice associated with naproxen. , 1974, Lancet.
[45] J. L. Grech,et al. Hepatitis with biliverdinaemia in association with indomethacin therapy. , 1967, British medical journal.
[46] J. Jacobs. Sudden death in arthritic children receiving large doses of indomethacin. , 1967, JAMA.
[47] M. Scharyj,et al. Fatal hepatitis probably due to indomethacin. , 1967, JAMA.